MARJORIE TUCKER: Open Payments
NPI 1538875729 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,300 in 67 payments from 15 companies in 2025. Trend: 2023 $125 · 2024 $1,164 · 2025 $1,300
Food & beverage: $1,300
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $307 |
| Corcept Therapeutics | 7 | $239 |
| Lilly USA, LLC | 14 | $183 |
| Novo Nordisk Inc | 8 | $152 |
| Axsome Therapeutics, Inc. | 4 | $93 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Merck Sharp & Dohme LLC | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| PFIZER INC. | 2 | $34 |
Products named: Korlym, VRAYLAR, JARDIANCE, Wegovy, MOUNJARO, Symbravo, LEQVIO, Kerendia.
Industry payments across TX — which companies pay providers there.
